Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-11-006559
Filing Date
2011-04-18
Accepted
2011-04-18 16:05:17
Documents
1
Period of Report
2011-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4277
  Complete submission text file 0001179110-11-006559.txt   5442
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 11765580